Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine vs EMLA for Spinal Needle Pain in LSCS
NCT04050059Completed
- Sponsor
- Aga Khan University
- Start
- Nov 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised, open-label trial in pain comparing 2% Lidocaine group with EMLA cream group (2 arms). Primary endpoints: Subjective Pain Score, Objective Pain Score and 1 more. Started Nov 2019; status: completed.
02
Drugs
lidocaine + prilocaineLidocaine Hydrochloride Injection, without epinephrine
03
Conditions
pain
Beyond the preview
Go deeper on NCT04050059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04050059.